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ABSTRACT
Enhancement of the bioavailability of poorly water-soluble drugs is a challenging task in drug development. Currently 40% of new chemical 
entities are discovered as poorly water-soluble drugs. Solid dispersion is one of the best technology for improving solubility, dissolution rate, and 
bioavailability. Solid dispersion techniques are more useful for enhancing drug solubility for a combination of drug and inert carrier to improve 
wettability, reduced particle size, and converting amorphous particles. This article reviews various advantages, methods of solid dispersions, carriers 
used in solid dispersion, characterization, and marketed products.
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INTRODUCTION
Oral drug delivery is simplest, most popular, and easy route of the 
administration of drugs. Recently, more than 40% of active new 
chemical entities are identified as poorly water-soluble drugs [1,2]. 
After administration drug orally, it disintegrates in gastric fluids and 
then solubility of drug in gastric and/or intestinal fluids and then 
permeability takes place in the membrane of gastrointestinal track, and 
it reaches systemic circulation. Hence, poorly aqueous soluble drugs 
have critical to exhibit dissolution rate [3].
Based on the biopharmaceutical classification system (BCS), Class II 
and Class IV drugs have low aqueous solubility [4].
Noyes–Whitney equation gives some idea about the dissolution rate of 
poorly soluble compounds which might be improved to minimize the 
limitations of oral availability [5].
Dc/Dt = AD (Cs – C)/h
Where Dc/Dt is dissolution rate,
A is dissolution surface area,
D is compound diffusion coefficient,
Cs is the solubility of compound,
C is concentration of drug in time t,
h is thickness of diffusion layer in dissolving compound.
Solid dispersion has been the most efficient technique to improve 
the solubility, dissolution rate, and oral absorption of poorly aqueous 
soluble drugs [6].
Solid dispersion is defined as a dispersion of one (or) more active 
ingredients in inert carrier at solid state preparation using various solid 
dispersion techniques [7].
The mechanism to enhance solubility by solid dispersion technique 
involves complete removal of dry crystallinity of poorly soluble 
compound in a inert carrier. Prepared solid dispersion material is 
exposed to aqueous media; the carrier dissolves in media  and the 
drug is releases as fine colloidal particles. This will increases the 
surface area of drug particles and improve dissolution rate [8]. Drug in 
soluble hydrophilic carrier improves the dissolution rate by reducing 
particle size and increasing the particle porosity. The drug converts 
into crystalline form to amorphous state and improves wettability 
and dissolution of poorly water-soluble drugs. For better dissolution 
rate, purpose surfactant has been included. Surfactants are useful for 
better dissolution rate purpose. Surfactants are also helpful to avoid 
recrystallization and enhances potentiality of their solubility [9].
ADVANTAGES OF SOLID DISPERSION
Reduced particle size by increased surface area
Particle size is majorly impact on dissolution rate, especially low soluble 
drugs. Due to reduced particle size of drug, it may lead to increase in 
surface area and contact of more surface area to dissolution media. 
Hence, it results in more dissolution rate.
Improved wettability of drug particles
Due to increase wettability of drug particles leads to improve solubility 
of drug in dissolution media. The use of carriers with or without 
surface active agents increases drug wettability. Carriers enhance drug 
solubility in dissolution media due to increased wettability of drug 
particles.
Particles with high porosity
By use of solid dispersion technique, The carriers are having high 
degree of porosity. carriers are useful to increases in porosity of drug 
particles which results improves solubility. For example, hypromellose 
and some of polymers have a high degree of porosity in nature. Hence, it 
enhances the solubility of drug in dissolution media and it leads to high 
dissolution rate compared to initial drug particles.
Drug particles polymorphic state
Polymorphic form of drug particles plays a major role in drug solubility 
in dissolution media. Crystalline nature of drug particles has less 
solubility comparative to amorphous drug particles. Crystalline 
polymorphic form of drug particles requires more energy to break 
the crystalline lattice, whereas amorphous drug particles require less 
energy to break the particles. Using additional surface active agents, it 
will more useful for the enhancement of solubility in dissolution media.
Solid dispersion
Based on solid-state structure and carriers, solid dispersions are 
classified into different ways. Solid dispersion was performed using 
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different methods based on molecular structure and nature. To 
enhance the solubility of active pharmaceutical ingredient (API), 
various preparations of solid dispersions were used based on principle 
and mechanism. Riegelman and Chiou classified solid dispersions into 
the following six representative types: Amorphous precipitations in 
a crystalline carrier, simple eutectic mixtures, solid solutions, glass 
solutions and glass suspensions, compound or complex formation, 
and combinations of the previous five types. Given below is the 
classification of solid dispersion on the basis of carrier used and solid 
structure [10].
First generation
In the first generation, solid dispersions was developed by crystalline 
carriers. In general, the crystalline carriers such as sugar and urea 
are used. The crystalline carriers are thermodynamically more 
stable. But the disadvantage is some of drugs are not suitable with 
Solid dispersions









Fig. 1: Schematic representation of aqueous soluble drug
Fig. 2: Classification of solid dispersion on the basis of carrier used
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crystalline carriers its cannot release the drug in dissolution media 
because of crystalline nature of API. In this crystalline carriers 
unable to convert drug nature from crystalline to amorphous. By 
presence of crystalline nature of drug it leads to  low solubility and 
bio availability [11,12].
Second generation
The second-generation solid dispersions are used as amorphous 
carriers instead of crystalline carriers like polymers. When 
compared to the first generation, second-generation carriers are 
more helpful by converting drug in amorphous nature, which was 
more useful for drug solubility in dissolution media. Different 
polymers such as polyvinylpyrrolidone (PVP), hydroxypropylmethyl 
cellulose (HPMC), polyethylene glycol (PEG), and HPMC. Using 
these polymers, the drug nature was converted and improves in 
bioavailability [13,14].
Third generation
Nowadays, the third-generation solid dispersions are used continuously 
for improving better solubility purpose. In this third generation, 
both the combination of surfactant and polymers and combination of 
polymers were used. It will more helpful for converting drug crystalline 
nature to amorphous nature and improved solubility in dissolution 
media because of surfactant. In this third generation solid dispersion 
technique is most effective to enhance solubility and bio availability of 
poorly  water soluble drugs [15,16].
Preparation of solid dispersions
Many methods are used for the preparation of solid dispersion systems, 
and some of them are enlisted as follows:
1. Spray drying
2. Hot melt extrusion method
3. Solvent evaporation method
4. Fusion/melting method
5. Melting solvent method
6. Lyophilization techniques
7. Melt agglomeration process
8. Electrospinning method
9. Supercritical fluid technology.
Spray drying
Spray drying technique is one of the most effective and commonly used solid 
dispersion methods. It is a single step, convenient, and easy to reproducible 
process. Mainly principle involved in spray dry technique is continuous 
transformation of converting material from liquid state to solid state using a 
heat drying chamber. In this process drug, polymer, sometimes surfactants, 
dissolves in solvent and continuous spraying in heating chamber where 
solvent is evaporated and converted into solid state [17].
In this drying chamber, solvent is sprayed using atomization air. The 
solvent is converted into fine droplets due to atomization air and 
converts solid particles in drying chamber.
Fig. 3: Schematic diagram of spray dryer
Fig. 4: Schematic diagram of hot melt extrusion
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In this technique, drug and inert carriers were complete dissolve 
in suitable solvent. The solvent used was single solvent or mixture 
of solvents based on the solubility of drug and inert carriers. Due to 
the solubility of drug and inert carriers, drug particles converted its 
crystalline nature to amorphous nature and it improves the solubility 
and bioavailability.
Polymers generally used as PVP, copovidone, HPMC, hydroxy propyl 
cellulose, and Soluplus surfactants as sodium lauryl sulfate, docusate 
sodium, and polysorbates. The drying chamber temperature was 
selected based on boiling point of solvents used. Different solvents are 








Hot melt extrusion method
Recently, hot melt extrusion method is more popular due to most of 
the formulation focusing in this technique to improve the solubility 
of poorly soluble drugs. The advantage of hot melt extrusion is less 
process time, effective technique of converting crystalline polymorphic 
form to amorphous polymorphic form. The main selection of hot melt 
extrusion technique rather than spray drying technique due to very less 
solubility of drug in solvent will require more solvent for dissolving 
drug in media. In this technique, there was no need of solvent. Hence, 
Fig. 6: Schematic diagram of melting solvent technique
Fig. 5: Schematic diagram of solvent evaporation technique
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depending on physicochemical property of drug, molecular hot melt 
technique was selected [19].
Hot melt extrusion is a continuous process to apply heat and pressure 
to melt a drug and polymer mixture in different heating chambers. 
Finally, the melted mixture reaches cooling chamber and it converts 
into solid flakes. Melting reaches up to glass transition temperature 
(Tg) of polymeric material. The selection of polymers depending on 
drug melting point [20].
Fig. 7: Schematic diagram of lyophilizer technique
Fig. 8: Schematic diagram of supercritical fluid technique
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In general, rotavapor is used for solvent evaporation method. In this 
method, drug and polymer dissolve in common organic solvent and 
the solvent is evaporated at low temperature. Then, the resulting 
mixture is milled through suitable screens. Some of the products are 
not suitable in this technique because only single solvent is utilized in 
this process. If drug is soluble in one solvent and polymer is dissolved 
in another solvent at the time of evaporation, solvents are evaporated 
based on boiling point, so drug or polymer solidified quickly based on 
the solvent used. It will lead to not complete  polymorphic conversion 
occurs. So finally creates a low soluble and low dissolution rate. 
Hence, drug and polymer dissolve in single solvent only. The selection 
of polymer is based on drug nature and solubility of drug in organic 
solvent. In general, solvents used ethanol, acetone, isopropyl alcohol, 
and dichloromethane. [21,22].
Fusion/melting method
In this process melting of drug with inert carrier at particular temperature, 
it produces the waxy type material by combined of drug particles with 
inert carrier. Then, waxy material placed in cooling chamber and milling 
through suitable screen. The main disadvantage is drugs which are 
having temperature sensitive or low melting point not suitable in this 
technology. In general, melt granulation through rapid mixer granulation 
is used in this method. In this process, heat is produced continuously in 
outside of the chamber and inside of chamber drug, and the drug and 
carrier rapid mixing takes place at certain time, it converts waxy type 
material. Later, cool water is circulated outside of chamber, it converts 
solid mass, and then, it places to milling and mixing [23,24].
Melting solvent method
Melting solvent method is a combination of both processes at a time, 
i.e., melting and solvent evaporation method. In this technology, drug 
is dissolved in suitable solvent after getting clear solution directly 
incorporated into melt of suitable carrier. Then, continuous low heat 
circulated in outside until the complete solvent is evaporated. The 
resulting residue is the combination of drug and inert carrier then 
solidified it properly [25]. The solid material is milled with suitable 
screen and mixed with other excipients. The main advantage of this 
method is drugs which are having low melting and high temperature-
sensitive drugs which are suitable in this method [26,27].
Lyophilization techniques
It is also called as freeze-drying in this process drug, and inert carrier 
dissolves in common solvent. The solution is frozen and sublimation 
under vacuum. The frozen state material is placed in low air pressure 
and it converts in glassy-like structure. The advantage of this process 
is minimal thermal stress and risk of phase separation is low. It is a 
technology that the drug substance maintains quality and stable [28,29].
Melt agglomeration process
In this technology, drug and polymer or binder is placed in continuous 
mixing chamber. Then generates heat based on the melting point of 
drug.  then drug and inert carrier mixing together and formulates a 
agglomerates. In this process find particles are melted together and 
forms a agglomerates. By enhancing dissolution rates use surfactants 
also. In this method resulting flowable material obtains to increases 
flow properties [30,31].
Electrospinning method
This is a nanotechnology majorly used for polymer industry. In this 
method, a liquid stream of drug and polymer solution involves into 
potential between 5 and 30 Kv. When electric forces overcome to surface 
tension of drug and polymer solution at air interface, it involves the 
strong electrostatic field over a polymer solution to form a submicron 
diameter fibers [32]. The fiber diameter completely depends on 
dielectric constant, surface tension, electric field strength, and feeding 
rate [33,34].
Supercritical fluid (SCF) technology
Using SCF technology to prepare solvent free dosage forms. It is a single 
fluid phase above the critical temperature and pressure. Carbon dioxide 
is commonly used for supercritical fluid as chemically inert nature, non-
flammable, and non-toxic. In this process, drug particles soluble with 
supercritical fluid and then recrystallization with reduced particle size 
as per requirement. The carbon dioxide is used for anti-solvent purpose 
[35,36].
CARRIERS USED IN SOLID DISPERSION [37]
PVP
PVP is used in a different pharmaceutical formulation mainly solid 
oral dosage forms. It is a fine, odorless, white to creamy white-colored 
hygroscopic material. It is available in different grades divided in its 
K-value. Based on molecular weight, K value available. K-value is from 
12 to 120 having molecular weight of 2500–3,000,000. Melting point of 
PVP is 150°C.The solubility is freely soluble in water, acids, chloroform, 
methanol, and ethanol. The viscosity of aqueous solubility depends on 
its molecular weight and concentration used [38,39].
Copovidone
Copovidine is commonly used as a carrier of spray dry technology due 
to its low viscosity and better binding property. The description of 
copovidone is a white to yellowish white color, and it is slightly have odor 
component. The melting point of copovidone is 140°C and it is a stable 
component. The Tg of copovidone is 106°C. Due to low-temperature 
glass transition nature, it is used as hot melt extrusion technology also. 
The solubility of copovidone is freely soluble in water, glycerol, PEG 400, 
and ethanol. The viscosity is <10 mPas at a concentration <10% [40].
HPMC
It is also called as hypromellose. It is widely used in many pharmaceutical 
dosage forms in different ways due to its viscosity ranges. The 
description of hypromellose is white to creamy white fibrous material 
of odorless, and it is hygroscopic in nature. It is available in various 
viscosity ranges of very low viscosity 3 mPas to high viscous range 
of 200,000 mPas. The melting point is about 190–200°C and Tg is 
170–180°C. the solubility of hypromellose is soluble in cool water 
and n hot water, ethanol, ether, and dichloromethane. Hypromellose is 
repeatedly used as a carrier in hot melt technology for conversion of 
crystalline polymorphic form to amorphous polymorphous form which 
was useful for improving solubility [41,42].
Hydroxypropyl cellulose (HPC)
HPC is an cellulose where some of the hydroxyl groups of the cellulose have 
hydroxyl propylated forming groups. It is a white to slightly yellow-colored 
odorless powder. HPC is commonly available in different grades depending 
on its viscosity. The viscosity ranges from 50,000 to 1,250,000 mPas. It is 
Very soluble <1
Freely soluble From 1 to 10
Soluble From 10 to 30
Sparingly soluble From 30 to 100
Slightly soluble From 100 to 1000
Very slightly soluble From 1000 to 10000
Practically insoluble 10,000 and over
Table 1: Solubility criteria as per USP and BP descriptive term 
part of solvent required per part of solute
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a stable molecular having melting point 130°C. The solubility of HPC is 
freely soluble in water, soluble 1 in 10 parts dichloromethane, and 1 in 2.5 
parts in ethanol. The pH of HPC is 5.0–8.0 [43].
PEG
PEG is a hydrophilic substance. It is available in different grades based 
on different molecular weights of PEG 200–8000 having molecular 
weights 190–9000. It is available in both liquid form and solid forms 
up to grade PEG 400 which are liquid materials. The description of PEG 
liquid grades is clear slightly yellow color and solid PEG is off-white in 
color. It is having very low melting point of 37–48°C. Due to its very low 
melting, nature may have stability problems. The solubility of PEG is 
freely soluble in water, glycerine, acetone, and alcohol [44,45].
Soluplus
Soluplus is a graft copolymer it contains combination of polyvinyl 
caprolactam, polyvinyl acetate, and PEG. The description of Soluplus is 
white to slightly yellowish granules. It is a hydrophilic carrier polymer 
majorly designed for poorly soluble drugs. The advantage of Soluplus 
improves solubilization property and enhances bioavailability. Due 
to its excellent extrudability, it is mainly used as a hot melt extrusion 
process to improve solubility. The solubility of Soluplus is freely soluble 
in water, acetone (up to 50%), and methanol (up to 45%). The Tg is 
70°C.
Carboxymethyl cellulose
The carboxymethyl cellulose is a stable, hygroscopic substance and 
description is white to almost white odorless granular powder. It 
is available in different viscosities of low to high (10–12,000). It is 
practically insoluble in water and melting point also high 220°C. It has 
both binder and disintegrate properties [46,47].
Hypromellose acetate succinate
Hypromellose acetate succinate is a white to off-white powder and 
available in several grades according to the pH at which polymer 
dissolves (low - L, medium - M, and high - H). the molecular weight 
is approximately 55,000–93,000 Da. It is a solubility-enhancing agent 
through solid dispersion and is insoluble in gastric fluid but will 
swell and dissolve rapidly in the upper intestine. The Tg is 113°C. The 
solubility is a mixture of ethanol and dichloromethane in 1:1 ratio [49].
Hypromellose phthalate
Hypromellose phthalate is a white to slightly off-white freely flowing 
flakes granular odorless powder. Hypromellose phthalate is a cellulose 
in which some of the hydroxyl groups are replaced with methyl esters. 
Different types of hypromellose phthalate are commonly available with 
molecular weight in a range of 80,000–130,000 Da. It is a hygroscopic 
material having Tg of 137°C and melting point of 150°C. The solubility 
is a mixture of acetone and methanol or ethyl alcohol 1:1 ratio [50].
Acids
In general, acids are high soluble components and are used as pH 
modifiers in pharmaceutical dosage form which was useful for pH-
sensitive molecules. Mainly citric acid monohydrate and tartaric acid are 
commonly used in the formulation. These are transparent crystalline, 
hygroscopic nature. The low melting point acids are converts into 
soften in nature. Different grades are available based on particle size 
difference [51].
Sugars
Simple sugars are named as monosaccharides which include sucrose, 
dextrose, glucose, and fructose. A part from this sugar alcohol is available 
which is called as polyols including sorbitol, mannitol, and xylitol. Sugars 
are high soluble hygroscopic substances. The melting point range is 
160–186°C. Sugar alcohols are freely soluble non-hygroscopic substances. 
These are commonly used as solid oral dosage forms as a plasticizer and 
diluent. Compared to sugars, sugar alcohols are stable substances. The 
common melting range is 166–168°C. it is suitable as moisture-sensitive 
active ingredients due to its non-hygroscopic nature [52].
Surfactants
Surfactants play a major role in pharmaceutical products. Surfactants 
are surface active agents which reduce surface tension. It improves 
the wettability of solid surface of drug particles it leads to improved 
solubility. In solid dispersion technology surfactants used for 
combination of polymers because it enhances solubility, dissolution 
rate and improves the bioavailability. It is classified into four types: 
Anionic, nonionic, cationic, and amphoteric surfactants [53].
Anionic surfactants
It dissolves in water negatively charged particles created. Sodium lauryl 
sulfate is anionic surfactant commonly used in formulations.
Cationic surfactants
It dissolves in water positive-charged particles created. Quaternary 
ammonium salts and amines with amide linkages are some of the 
examples of cationic surfactants.
Non-ionic surfactants
It contains hydrophilic groups. Tweens and spans are common examples 
of non-ionic surfactants.
Amphoteric surfactants
These are also called as zwitterionic surfactants and it contains both 
anionic and cationic centers attach to the same molecular. Examples are 
sodium dodecyl sulfates phospholipids.





5. X-ray powder diffraction (XRD) studies
6. Fourier transform infra red (FTIR) spectroscopy
7. Differential scanning calorimetry (DSC).
Physical appearance
It involves the appearance of solid dispersion by visual inspection.
Drug content
It is a analysis of the amount of drug present in solid dispersion. 
The assay method of drug is taken and dissolved in suitable solvents 
which ensure that freely soluble in nature and dilute it in appropriate 
concentration. Finally drug content measured by UV or high 
performance liquid chromatography (HPLC) method.
Dissolution
Dissolution measures the dissolve component at particular time period. 
The percentage of drug release at particular time period measured 
by basically UV or HPLC methods. The study is performed at pre-
determined volume and RPM at 37±0.5°C. As per USP 7 dissolution 
apparatus are available. Commonly, basket or paddle apparatus is used 
Eudragits
Eudragits are regularly used in pharmaceutical solid oral dosage forms 
containing synthetic  cationic  and anionic  polymers.  It  is  also 
called  as  polymetha  acrylates.  It  is  available  as  different  stages 
(dispersion,  solid,  and  organic  solutions)  and  different  grades  are 
having  different  applications  based  on  pH  dependent  and  pH 
independents.  Typically,  the  molecular  weight  of  polymer  is 
above 100,000. Eudragit E is soluble in gastric fluids about pH 
5,  Eudragit  L  is  soluble  in  above  6,  and  Eudragit  S  are  soluble  in 
above pH 7. Eudragit RL are forms water- insoluble film and are more 
permeable  than  those  of  Eudragit  RS.  The  solubility  of  eudragits  is  a 
mixture of organic solvents isopropyl alcohol, acetone, and water [48].
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for solid oral dosage forms.
USP app Description Dosage forms
Apparatus I Basket Conventional, chewable 
and controlled-release 
tablets, capsules
Apparatus II Paddle Conventional tablets, ODT, 
ER
Apparatus III Reciprocating cylinder CR and chewable tablets
Apparatus IV Flow-through cell ER, poorly soluble 
API formulations, 
microparticles, implants
Apparatus V Paddle over disk Transdermal
Apparatus VI Cylinder Transdermal
Apparatus VII Reciprocating holder CR (non-disintegrating oral 
and transdermal)
Scanning electron microscopy
It is used to find the images of sample by scanning to surface of material 
with focused beam. Electron microscopy is helpful to morphological 
structure of material.
XRD studies
Powder XRD studies play a major role for identifying polymorphic 
forms, i.e., crystalline or amorphous. Based on diffracted beam angles 
and intensities of molecular structure to particular drug components 2 
theta values occurs.
FTIR spectroscopy
FTIR spectroscopy gives a clear picture of interaction between drug to 
drug and drug to excipients. It measures intensity over a narrow range 
of wavelengths at a time.
DSC
DSC is a thermoanalytical technique which measures endothermic and 
exothermic reactions by increasing temperature gradually. Endothermic 
reactions measure melting and boiling points. Exothermic reactions 
measure crystallization and polymerization (Table 2).
CONCLUSION
Solid dispersion system is extremely useful for improving solubility 
and dissolution rate of poorly water solubility drugs, i.e., BCS Class II 
and IV drugs. The various solid dispersion techniques described 
above are useful to improves the solubility of drug substance. Based 
on drug nature, the selection of solid dispersion method is required 
for the enhancement of bioavailability. Drug is exposed to carrier in 
the presence of solvent the resultant mixture which is fine colloidal 
particles to produce higher bioavailability. It can significantly increase 
porosity and wettability properties of drug. Sometimes, surfactants 
are also useful for better improvement of dissolution rate. For higher 
solubility rates, optimization of polymer and surfactant concentration 
is required.
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